Prognostic Liver Signature for NAFLD (PLS-NAFLD) profiles of cell-based PLS system treated with free fatty acids (FFA) and IDO1 inhibitor, epacadostat.

Accession: GSE200460
Source / host: GEO — NCBI GEO FTP
Disease relevance: MASLD / NAFLD / NASH (category: Multi-omics/other, subtype: mixed/other assay)
Modality / assay: other
Platform: Other, GPL32152
Organism: human
Samples: 14
Size (indexed): 15.6 KB (15944 bytes)
Downloaded bytes: 15.6 KB (15944 bytes)
Access / raw: public / OPEN-raw

Download

Files

FileSizeSHA256
GSE200460_Huh751.LX2_PLS.NAFLD_normgene_geomean_scale_log2.gct.gz9.7 KB2143e2225940f0d9…
GSE200460_raw_counts.txt.gz5.9 KB40988d49bfddd9e5…

Index note: 2 suppl file(s); GSE200460_raw_counts.txt.gz

Crawled by masld-atlas-crawler v1.0 at 2026-08-02T16:27:00Z.

About this dataset

This Other, GPL32152 dataset provides single-cell gene expression from human liver samples, with disease state recorded as MASLD/NAFLD/NASH. It profiles about 14 cells or nuclei.

Analyze it in Drylab

Open this dataset in Drylab and ask a question in plain language. The AI agent loads the files, runs the analysis in a ready sandbox and explains each result. A typical first pass:

  1. Load the filtered feature-barcode matrix (HDF5) and run quality control on counts, genes and mitochondrial reads per cell.
  2. Normalize, select variable genes, then cluster the cells and draw a UMAP.
  3. Annotate clusters with marker genes and compare the cell-type mix between conditions.
  4. Run differential expression between cell types or samples to characterize masld/nafld/nash biology.